innat
immun
respons
provid
first
line
defens
virus
pathogen
respond
specif
microbi
molecul
influenza
viru
iav
produc
doublestrand
rna
intermedi
replic
life
cycl
activ
intracellular
pathogen
recognit
receptor
rigi
induc
product
proinflammatori
cytokin
antivir
interferon
understand
mechan
regul
innat
immun
respons
iav
virus
key
import
develop
novel
therapeut
strategi
use
myeloid
cell
specif
knockout
mice
examin
role
ubiquitinedit
protein
respons
myeloid
cell
iav
infect
defici
macrophag
hyperrespons
doubl
strand
rna
iav
infect
illustr
enhanc
nfkb
activ
concomit
increas
product
proinflammatori
cytokin
chemokin
type
interferon
vivo
associ
increas
number
alveolar
macrophag
neutrophil
lung
iav
infect
mice
surprisingli
myeloid
cell
specif
knockout
mice
protect
lethal
iav
infect
result
challeng
gener
belief
excess
host
proinflammatori
respons
associ
iavinduc
lethal
suggest
certain
condit
inhibit
might
interest
manag
iav
infect
virus
class
highli
divers
pathogen
depend
host
cell
replic
initi
protect
innat
antivir
immun
respons
involv
action
special
pattern
recognit
receptor
prr
detect
conserv
molecular
structur
invad
pathogen
trigger
prr
induc
product
host
proinflammatori
cytokin
eg
tnf
type
interferon
interferona
ifna
ifnb
activ
downstream
signal
pathway
control
variou
transcript
factor
nfkb
presenc
viral
nucleic
acid
viral
rna
dna
viral
replic
intermedi
viral
transcript
product
sens
specif
intracellular
prr
endosom
tolllik
receptor
tlr
cytoplasm
rna
helicas
rigilik
receptor
rlr
nodlik
receptor
nlr
detect
presenc
viral
singl
strand
doubl
strand
rna
rigi
intracellular
dna
sensor
mediat
antivir
immun
respons
dna
virus
includ
dai
pyhin
domain
contain
protein
tlr
mediat
antivir
respons
restrict
special
type
ifn
produc
plasmacytoid
dendrit
cell
pdc
cell
type
includ
convent
dc
cdc
macrophag
fibroblast
depend
cytosol
rna
dna
sensor
product
antivir
protein
influenza
viru
iav
etiolog
agent
contagi
acut
respiratori
diseas
caus
consider
mortal
gener
believ
due
excess
host
inflammatori
respons
emerg
drugresist
strain
influenza
virus
pandem
potenti
underscor
import
develop
novel
antivir
strategi
context
understand
mechan
regul
iavinduc
immun
respons
critic
iav
infect
lead
exposur
host
cell
singlestrand
genom
rna
doubl
strand
rna
latter
intermedi
viral
replic
rigi
implic
sensor
iav
infect
receptor
contribut
proinflammatori
respons
iav
initi
innat
antivir
immun
respons
larg
depend
rigi
mediat
signal
interestingli
rigi
defici
mice
highli
suscept
iav
wherea
defici
mice
surviv
advantag
acut
infect
result
indic
imbal
benefici
harm
effect
mediat
releas
immun
cell
like
contribut
pathogenesi
influenza
rigi
contain
ctermin
dexdh
box
helicas
domain
requir
ligand
recognit
two
ntermin
card
domain
upon
ligand
bind
card
domain
rigi
associ
card
domain
mav
also
term
visa
cardif
adaptor
protein
subsequ
transloc
insert
outer
mitochondri
membran
via
ctermin
transmembran
domain
signal
downstream
mav
requir
action
variou
ubiquitin
modifi
enzym
posit
neg
regul
rigi
mediat
signal
transduct
ubiquitin
ligas
riplet
shown
directli
promot
rigi
activ
addit
well
character
ubiquitin
ligas
mediat
respect
nfkb
activ
upon
rigi
stimul
hand
deubiquitin
enzym
dub
duba
cyld
shown
neg
regul
rlr
signal
specif
remov
polyubiquitin
chain
sever
signal
molecul
furthermor
variou
ubiquitin
ligas
mark
respect
mav
proteasom
mediat
degrad
thu
inhibit
downstream
signal
addit
attach
polyubiquitin
chain
transcript
factor
raul
dampen
antivir
signal
transduct
ubiquitinedit
enzym
belong
otudomain
famili
dub
interestingli
also
harbor
atyp
zinc
finger
depend
ubiquitin
ligas
activ
catalyt
noncatalyt
mechan
previous
shown
involv
neg
regul
proinflammatori
signal
respons
multipl
receptor
tnf
receptor
antiinflammatori
role
clearli
demonstr
fact
defici
mice
die
earli
birth
due
sever
multiorgan
inflamm
cachexia
recent
gene
target
specif
cell
type
shown
associ
autoimmun
chronic
inflamm
illustr
import
brake
inflammatori
respons
relev
find
human
diseas
recent
illustr
identif
polymorph
locu
associ
sever
autoimmun
diseas
chronic
inflamm
contrast
well
establish
function
regul
proinflammatori
respons
role
regul
antivir
immun
respons
less
well
describ
limit
number
vitro
studi
use
overexpress
silenc
specif
cell
line
indic
may
regul
rigiand
signal
nfkb
howev
precis
vivo
role
respons
viral
infect
remain
clarifi
use
myeloid
cell
specif
knockout
mice
myelko
recent
gener
lab
primari
cell
deriv
mice
provid
evid
crucial
neg
regul
iavinduc
proinflammatori
antivir
signal
macrophag
interestingli
myelko
mice
show
enhanc
surviv
reduc
morbid
respons
iav
lung
infect
compar
wild
type
mice
protect
iav
myelko
mice
associ
increas
cytokin
chemokin
product
augment
recruit
innat
immun
cell
neutophil
alveolar
macrophag
enhanc
viral
clearanc
result
suggest
boost
innat
immun
respons
iav
target
activ
myeloid
cell
might
therapeut
potenti
rigi
signal
induc
activ
nfkb
transcript
factor
promot
express
proinflammatori
cytokin
type
ifn
restrict
viral
propag
previou
studi
shown
ectop
express
neg
regul
nfkb
activ
upon
rigi
stimul
similarli
show
overexpress
cell
prevent
nfkband
luciferas
report
gene
activ
induc
transfect
truncat
constitut
activ
form
rigi
correspond
two
ntermin
card
domain
rigi
rigi
figur
left
middl
graph
next
investig
whether
also
inhibit
activ
unlik
weakli
express
condit
protein
level
rapidli
upregul
upon
virusinduc
activ
determin
effect
activ
therefor
transfect
minor
amount
express
plasmid
togeth
plasmid
encod
rigi
luciferas
report
construct
rigi
express
absenc
coexpress
show
neglig
promot
activ
grey
bar
figur
right
graph
wherea
signific
report
gene
express
observ
presenc
similar
inhibitori
effect
nfkb
activ
also
prevent
rigiinduc
activ
figur
right
graph
result
demonstr
potenti
inhibit
rigiinduc
nfkb
activ
studi
effect
endogen
express
rigiinduc
signal
immunolog
relev
context
perform
experi
defici
primari
macrophag
sinc
full
knockout
mice
die
prematur
result
influenza
viru
flu
epidem
repres
recurr
threat
public
health
especi
individu
part
highrisk
group
children
elderli
immunecompromis
peopl
sporad
pandem
flu
outbreak
spanish
flu
may
caus
high
grade
mortal
among
healthi
person
better
understand
immun
system
deal
pathogen
key
import
protein
import
neg
regul
innat
adapt
immun
respons
show
specif
delet
myeloid
cell
macrophag
neutrophil
improv
resist
otherwis
lethal
influenza
infect
protect
effect
mediat
enhanc
innat
immun
respons
follow
respiratori
challeng
influenza
viru
although
exagger
pulmonari
immun
respons
believ
primari
caus
often
life
threaten
influenza
viru
induc
pneumonia
demonstr
boost
innat
immun
respons
select
target
function
myeloid
cell
benefici
host
surviv
find
provid
us
novel
valuabl
approach
treat
influenza
potenti
respiratori
viral
infect
sever
multiorgan
inflamm
gener
mice
carri
condit
allel
exon
iv
exon
v
flank
two
loxp
site
cross
mice
transgen
mice
express
cre
recombinas
control
lysozym
promot
lead
specif
delet
myeloid
cell
allow
us
gener
myeloid
cell
specif
knockout
mice
stimul
rigi
receptor
transfect
myelko
bmdm
wild
type
control
cell
minim
amount
low
molecular
middl
depend
luciferas
report
right
plasmid
togeth
plasmid
express
rigi
right
increas
amount
luciferas
activ
cell
extract
analyz
luminomet
number
averag
sd
sampl
per
setup
bd
myelko
wild
type
myelwt
bmdm
transfect
lmw
poli
c
analyz
differ
time
point
minut
start
transfect
ikba
phosphoryl
degrad
phosphoryl
immunoblot
total
cell
extract
b
band
nonspecif
recogn
antiikba
antibodi
indic
asterisk
use
load
control
nuclear
transloc
nfkb
analyz
immunoblot
cytoplasm
nuclear
fraction
c
quantif
band
densiti
nuclear
shown
bar
graph
express
rel
densiti
compar
first
lane
time
tnf
ifnb
level
supernat
cell
use
b
determin
bioassay
elisa
tnf
ifnb
describ
materi
method
section
data
repres
independ
experi
weight
lmw
poli
c
known
preferenti
bind
activ
rigi
rather
note
concentr
poli
c
unabl
induc
signific
depend
nfkb
activ
cytokin
product
data
shown
expect
poli
c
transfect
induc
rapid
express
wild
type
myelko
bmdm
figur
upper
panel
earli
time
point
slightli
slower
migrat
form
observ
indic
undergo
yet
unknown
modif
upon
poli
c
transfect
compar
wild
type
bmbm
defici
cell
show
enhanc
nfkb
activ
indic
increas
phosphoryl
sustain
degrad
ikba
figur
furthermor
nuclear
transloc
nfkb
subunit
enhanc
poli
c
transfect
myelko
bmdm
reach
maximum
earlier
time
point
compar
wild
type
cell
figur
known
activ
upon
phosphoryl
seri
carboxyl
termin
serin
residu
ikklik
kinas
ikk
e
lead
dimer
subsequ
transloc
nucleu
use
immunoblot
antibodi
direct
phosphoryl
maximum
phosphoryl
detect
earlier
time
point
myelko
bmdm
compar
wild
type
bmdm
figur
similar
nuclear
transloc
reach
maximum
earlier
time
point
defici
bmdm
compar
wild
type
cell
figur
nfkb
control
express
tnf
nfkb
control
express
ifnb
line
enhanc
activ
nfkb
describ
myelko
bmdm
secret
increas
amount
tnf
ifnb
figur
similar
result
obtain
use
periton
macrophag
data
shown
togeth
result
demonstr
play
import
role
neg
regul
rigiinduc
nfkb
activ
primari
macrophag
investig
role
iavinduc
proinflammatori
antivir
innat
immun
respons
infect
defici
control
bmdm
iav
mrna
level
rapidli
induc
wild
type
bmdm
defici
bmdm
upon
viral
infect
figur
furthermor
myelko
bmdm
show
enhanc
express
ifnb
mrna
iav
infect
compar
control
cell
figur
accord
data
cell
cultur
supernat
collect
cell
contain
higher
level
tnf
ifnb
figur
upon
host
infect
iav
alveolar
macrophag
import
sourc
cytokin
chemokin
attract
innat
immun
cell
lung
primari
phase
infect
test
whether
directli
control
iavinduc
gene
express
alveolar
macrophag
isol
cell
lung
myelko
control
litterm
infect
vitro
iav
express
secret
proinflammatori
cytokin
tnf
typei
ifn
ifnb
chemokin
kc
significantli
higher
iav
infect
cell
lack
compar
infect
wild
type
cell
figur
figur
taken
togeth
result
demonstr
neg
regul
iavinduc
proinflammatori
antivir
gene
express
alveolar
macrophag
consist
inhibitori
effect
seen
rigiinduc
nfkb
activ
determin
role
express
myeloid
cell
iav
infect
vivo
intranas
inocul
myelko
mice
control
litterm
subleth
dose
mous
adapt
iav
strain
monitor
morbid
term
weight
loss
myelko
mice
show
reduc
weight
loss
compar
wild
type
control
litterm
recov
faster
viral
challeng
figur
also
total
protein
concentr
bal
fluid
reflect
lung
damag
vascular
leakag
increas
significantli
day
post
infect
wild
type
myelko
mice
slightli
lower
myelko
mice
data
shown
next
measur
pulmonari
viral
titer
day
post
infect
differ
viral
titer
observ
myelko
mice
versu
wild
type
mice
day
post
infect
howev
day
almost
viru
could
detect
lung
myelko
mice
abund
infecti
viral
particl
could
still
isol
lung
wild
type
mice
figur
indic
loss
myeloid
cell
affect
earli
viral
replic
contribut
viral
clearanc
later
stage
infect
verifi
defici
myeloid
cell
affect
iavinduc
gene
express
lung
analyz
level
sever
chemokin
cytokin
bronchoalveolar
lavag
bal
day
day
follow
infect
level
kc
chemokin
well
significantli
higher
day
pi
bal
iav
infect
myelko
mice
compar
iav
infect
wild
type
mice
figur
unlik
observ
vitro
stimul
primari
macrophag
could
detect
signific
increas
ifna
product
lung
myelko
anim
figur
kc
murin
orthologu
serv
togeth
chemoattract
neutrophil
mainli
known
chemoattract
monocyt
eventu
develop
macrophag
upon
enter
alveolar
lumen
consist
higher
kc
level
myelko
mice
number
neutrophil
recruit
bronchoalveolar
space
upon
iav
infect
clearli
higher
throughout
infect
myelko
mice
compar
control
anim
figur
although
could
detect
signific
increas
monocyt
recruit
day
post
infect
evid
later
time
point
infect
figur
consist
equal
express
group
mice
number
resid
alveolar
macrophag
autofluoresc
also
elev
myelko
mice
differ
significantli
iav
infect
mock
infect
mice
figur
elimin
iav
infect
cell
depend
clonal
expans
viru
specif
cytotox
cell
ctl
test
whether
express
myeloid
cell
regul
antivir
ctl
respons
total
cell
viru
specif
granzym
b
grb
ifnc
express
cell
measur
bal
lung
parenchyma
wild
type
myelko
mice
clear
increas
cell
could
detect
day
post
infect
differ
observ
myelko
wild
type
mice
figur
figur
also
number
grb
ifnc
cell
well
ifnc
express
level
lung
alter
absenc
myeloid
cell
figur
protect
iav
infect
also
provid
humor
immun
respons
test
whether
loss
myeloid
cell
affect
b
cell
mediat
immun
determin
hemagglutinin
ha
antibodi
titer
serum
myelko
wild
type
litterm
howev
differ
could
detect
wild
type
myelko
anim
figur
indic
humor
immun
affect
express
myeloid
cell
togeth
data
suggest
mechan
adapt
immun
increas
innat
immun
respons
character
increas
influx
neutrophil
increas
number
alveolar
macrophag
contribut
better
viral
clearanc
myelko
mice
gener
believ
iavinduc
mortal
due
excess
proinflammatori
respons
lung
therefor
analyz
whether
increas
proinflammatori
cytokin
product
infiltr
proinflammatori
cell
myelko
mice
affect
mortal
induc
intranas
infect
lethal
dose
iav
surprisingli
almost
myelko
mice
surviv
control
mice
succumb
within
day
infect
figur
myelko
mice
still
show
signific
weight
loss
lung
damag
reflect
increas
total
protein
concentr
bal
data
shown
cours
infect
abl
recov
contrast
wild
type
mice
succumb
figur
similar
observ
subleth
iav
infect
pulmonari
kc
product
stronger
myelko
anim
compar
wild
type
mice
follow
lethal
iav
infect
figur
correl
increas
number
neutrophil
lung
mice
figur
also
level
proinflammatori
cytokin
tnf
often
associ
immunopathogenesi
human
increas
lung
myelko
mice
compar
control
anim
figur
figur
product
increas
even
lower
myelko
mice
figur
also
monocyt
recruit
differ
group
mice
could
also
detect
differ
viral
clearanc
antivir
adapt
immun
h
post
infect
figur
collect
data
indic
defici
myeloid
cell
associ
increas
innat
immun
respons
protect
lethal
iav
infect
present
studi
investig
contribut
express
myeloid
cell
innat
immun
respons
iav
lung
infect
pulmonari
environ
macrophag
popul
lung
parenchyma
alveolar
lumen
refer
alveolar
macrophag
condit
alveolar
macrophag
exert
import
immunomodulatori
function
howev
alveolar
macrophag
also
crucial
innat
immun
respons
iav
one
first
cell
encount
infecti
iav
particl
import
sourc
proinflammatori
cytokin
chemokin
attract
innat
immun
cell
lung
primari
phase
infect
primari
produc
type
ifn
alveolar
macrophag
also
known
phagocytos
viru
infect
apoptot
cell
antibodi
coat
viral
particl
contribut
viral
clearanc
could
show
bmdm
alveolar
macrophag
deriv
myelko
mice
express
higher
amount
chemokin
cytokin
type
ifn
compar
wild
type
mice
respons
vitro
infect
similarli
vivo
infect
iav
result
higher
level
primarili
neutrophil
attract
chemokin
kc
sever
proinflammatori
cytokin
tnf
lung
myelko
mice
compar
wild
type
mice
associ
select
enhanc
neutrophil
recruit
bronchoalveolar
compart
result
improv
viral
clearanc
later
infect
although
role
neutrophil
viral
infect
still
debat
recent
evid
support
protect
function
cell
iav
infect
level
affect
absenc
myeloid
cell
consist
notion
airway
epitheli
cell
primari
sourc
product
iav
infect
mice
defici
receptor
express
subset
circul
monocyt
protect
iav
infect
display
reduc
sign
immunopatholog
iav
infect
monocyt
develop
inflammatori
dendrit
cell
proinflammatori
macrophag
consid
major
contributor
iavinduc
immunopatholog
myelko
mice
protect
lethal
iav
infect
rather
surpris
sinc
excess
proinflammatori
cytokin
respons
excess
influx
inflammatori
cell
gener
believ
associ
increas
lethal
howev
select
effect
defici
neutrophil
recruit
without
alter
inflammatori
monocyt
recruit
support
idea
monocyt
neutrophil
major
contributor
iavassoci
immunopatholog
lethal
show
defici
bmdm
display
enhanc
nfkb
activ
respons
rigi
stimul
synthet
lmw
doubl
strand
rna
rigi
previous
shown
play
key
role
innat
immun
respons
iav
suggest
increas
immun
respons
myelko
mice
iav
lung
infect
reflect
enhanc
rigi
signal
propos
inhibit
iavinduc
proinflammatori
gene
express
shown
manuscript
tnf
kc
ifnb
neg
regul
nfkb
activ
major
pathway
control
gene
howev
exclud
addit
effect
signal
pathway
may
contribut
proinflammatori
gene
express
believ
exert
nfkb
inhibitori
function
modul
ubiquitin
statu
differ
signal
protein
context
recent
shown
cooper
ubiquitinbind
protein
disrupt
complex
therebi
neg
affect
ikk
abil
activ
whether
similar
mechan
involv
regul
rigi
induc
nfkb
activ
still
unclear
far
unabl
clearli
detect
ubiquitin
ikk
primari
macrophag
prevent
us
studi
effect
defici
ubiquitin
statu
exclud
howev
also
target
substrat
mediat
nfkb
activ
myeloid
cell
identif
substrat
topic
futur
investig
laboratori
multipl
deubiquitin
enzym
dub
duba
cyld
shown
neg
regul
rigi
signal
nfkb
implic
possibl
redund
howev
evid
far
limit
vitro
data
obtain
nonphysiolog
condit
clear
protect
phenotyp
myelko
mice
describ
indic
express
myeloid
cell
central
gatekeep
rigi
induc
signal
respons
iav
infect
dub
substitut
defici
physiolog
condit
similar
nonredund
role
cell
type
implic
respons
iav
lung
epitheli
cell
remain
investig
understand
control
activ
innat
antivir
immun
respons
import
step
toward
novel
therapi
fifth
world
popul
infect
iav
annual
lead
high
morbid
mortal
particularli
infant
elderli
immunocompromis
high
mutat
rate
iav
turn
attempt
vaccin
antivir
design
never
end
battl
recent
year
rna
interfer
trigger
synthet
short
interf
rna
sirna
rapidli
evolv
potent
antivir
regimen
properli
design
sirna
shown
function
potent
inhibitor
influenza
viru
replic
although
specif
tissu
deliveri
remain
major
bottleneck
clinic
applic
rnai
gener
intranas
applic
sirna
respiratori
virus
includ
limit
influenza
viru
experienc
signific
success
optim
result
suggest
sirna
target
iav
compon
boost
antivir
immun
respons
intranas
administr
sirna
might
valid
therapeut
approach
also
small
compound
inhibitor
might
interest
altern
final
similar
target
might
interest
battl
viral
infect
includ
rsv
sar
coronaviru
experi
mice
conduct
accord
nation
belgian
law
belgian
royal
decre
european
eu
direct
anim
regul
anim
protocol
approv
ethic
committe
ghent
univers
permit
number
approv
id
effort
made
amelior
suffer
anim
mice
anesthet
intraperiton
ip
inject
mixtur
ketamin
mg
kg
xylazin
mgkg
mice
flfl
mice
gener
previous
describ
flfl
mice
cross
lysmcr
mice
provid
institut
genet
univers
cologn
germani
gener
flfl
lysmcr
transgen
describ
detail
elsewher
mice
hous
individu
ventil
cage
vib
depart
molecular
biomed
research
specif
pathogenfre
anim
facil
influenza
infect
perform
age
week
old
sexmatch
litterm
flfl
lysmcr
anim
backcross
three
time
background
flfl
mice
express
lack
lysmcr
transgen
term
myelko
wild
type
myelwt
respect
mous
adapt
iav
propag
mdck
cell
viral
inocul
mice
anesthet
ip
inject
ketamin
mgkg
xylazin
mgkg
ml
dilut
pb
administ
intranas
lethal
subleth
infect
mice
receiv
respect
determin
pulmonari
viral
titer
median
tissu
cultur
infecti
dose
tcid
measur
follow
lung
homogen
polytron
homogen
kinematica
pb
eightfold
serial
dilut
lung
homogen
incub
mdck
cell
day
dmem
supplement
trypsin
mgml
mm
lglutamin
mm
sodium
pyruv
antibiot
readout
chicken
red
blood
cell
rbc
ad
endpoint
dilut
hemagglutin
monitor
tcid
titer
calcul
accord
method
reed
muench
determin
hai
titer
infect
mice
sera
treat
receptordestroy
enzym
rdecholera
filtrat
sigma
remov
sialic
acid
serum
protein
capabl
aspecif
inhibit
agglutin
incub
overnight
rde
inactiv
addit
sodium
citrat
pb
heat
min
remov
sialic
acid
bind
protein
sera
clear
volum
chicken
rbc
titrat
done
incub
twofold
dilut
seri
sera
ha
unit
viru
hour
room
temperatur
ubottom
plate
final
equal
volum
chicken
rbc
ad
titer
read
min
later
neg
control
includ
pb
instead
immun
serum
agglutin
control
instead
viru
control
agglutin
effect
sera
posit
control
serum
mous
infect
twice
subleth
dose
use
vivo
intracellular
grb
ifnc
stain
activ
cell
granzym
b
grb
ifnc
express
cell
determin
treat
mice
intranas
mg
brefeldin
sigma
previous
describ
h
later
bal
lung
isol
singl
cell
suspens
prepar
lung
presenc
mgml
brefeldin
cell
stain
fix
permeabil
cytofixcytoperm
bd
bioscienc
accord
manufactur
instruct
activ
cell
analyz
flow
cytometri
base
lo
express
livedead
fixabl
aqua
dead
cell
stain
kit
molecular
probe
use
discrimin
live
dead
cell
gener
bmdm
bone
marrow
cell
cultur
day
rpmi
gibco
supplement
fc
mm
lglutamin
mm
sodium
pyruv
antibiot
ngml
recombin
mcsf
bmdm
puriti
measur
flow
cytometri
use
specif
antibodi
isol
alveolar
macrophag
trachea
canul
lung
flush
time
hbss
contain
mm
edta
alveolar
macrophag
cultur
rpmi
gibco
supplement
fc
mm
lglutamin
mm
sodium
pyruv
antibiot
total
lysat
cell
lyse
min
lysi
buffer
mm
nacl
mm
trishcl
ph
mm
edta
mm
dtt
supplement
proteas
phosphatas
inhibitor
nuclear
cytoplasm
lysat
prepar
resuspend
cell
mm
hepe
ph
mm
kcl
mm
mgcl
glycerol
mm
edta
mm
egta
supplement
proteas
phosphatas
inhibitor
min
next
deterg
ad
final
concentr
cell
centrifug
g
min
nuclear
fraction
contain
pellet
lyze
mm
hepe
ph
mm
nacl
mm
kcl
mm
glycerol
mm
edta
mm
egta
supplement
proteas
phosphatas
inhibitor
min
lysat
subsequ
separ
sdspage
analyz
western
blot
ecl
detect
perkin
elmer
life
scienc
immunoblot
reveal
antiikba
antihiston
santa
cruz
invitrogen
antiphosphoikba
cell
signal
antiactin
mp
biomed
densiti
band
quantifi
fold
induct
imagej
http
rsbwebnihgovij
gel
analyz
tool
intens
calcul
rel
first
lane
time
lung
dissect
incub
collagenas
type
iv
mgml
sigma
dnase
uml
roch
percp
ifnc
alexa
bd
pharmingen
sampl
acquir
lsrii
cytomet
analyz
use
facsdiva
softwar
bd
bioscienc
propidium
iodid
use
discrimin
live
dead
cell
tnf
elisa
plate
coat
tnf
coat
ebiosci
detect
ebiosci
antibodi
ifna
ifnb
protein
level
determin
elisa
kit
pbl
biomed
laboratori
ifnc
elisa
plate
coat
ifnc
coat
detect
antibodi
ebiosci
detect
kc
tnf
bal
fluid
perform
use
bioplex
biorad
technolog
accord
manufactur
instruct
milliplex
technolog
millipor
use
detect
bal
fluid
total
rna
extract
use
aurum
total
rna
mini
kit
biorad
revers
transcrib
cdna
iscript
cdna
synthesi
kit
biorad
accord
manufactur
instruct
qpcr
perform
use
sybr
green
master
mix
roch
lightcycl
result
express
mean
sem
statist
signific
group
assess
use
twoway
anova
differ
vivo
experi
least
mice
per
group
calcul
use
mannwhitney
utest
unpair
data
statist
signific
differ
surviv
rate
analyz
compar
kaplanmei
curv
use
logrank
test
graphpad
prism
version
graphpad
san
diego
ca
figur
defici
alveolar
macrophag
hyperrespons
iav
infect
alveolar
macrophag
isol
myelko
wild
type
myelwt
mice
mock
treat
infect
iav
moi
hour
tnf
kc
mrna
express
determin
qpcr
cell
cultur
supernat
analyz
tnf
kc
protein
level
elisa
multiplex
technolog
b
error
bar
repres
mean
valu
sem
sampl
result
repres
independ
experi
tif
figur
adapt
immun
alter
absenc
myeloid
cell
follow
subleth
iav
infect
wild
type
myelwt
myelko
mice
infect
intranas
subleth
dose
iav
bal
isol
iav
infect
mice
day
pi
analyz
total
cell
granzym
b
grb
ifnc
express
cell
ifnc
protein
level
b
total
cell
grb
ifnc
express
cell
lung
parenchyma
also
determin
flow
cytometri
c
viru
specif
antibodi
titer
serum
day
pi
determin
via
hemagglutin
inhibit
hai
assay
dash
line
depict
detect
limit
assay
number
averag
sem
least
mice
per
group
repres
independ
experi
tif
figur
adapt
immun
alter
absenc
myeloid
cell
follow
lethal
iav
infect
wild
type
myelwt
myelko
mice
infect
intranas
lethal
dose
iav
day
pi
mice
sacrif
analyz
tnf
protein
level
bal
fluid
measur
elisa
multiplex
technolog
b
viral
titer
lung
measur
express
mean
tcid
dash
line
repres
detect
limit
c
total
grb
ifnc
express
cell
bal
fluid
measur
use
flow
cytometri
ifnc
protein
level
bal
fluid
measur
elisa
e
total
grb
ifnc
express
cell
lung
parenchyma
measur
use
flow
cytometri
f
viru
specif
antibodi
titer
serum
determin
via
hemagglutin
inhibit
hai
assay
dash
line
depict
detect
limit
number
averag
sem
least
mice
per
group
tif
